ICRA maintains stable outlook for Indian pharma companies
Domestic pharma cos expected to grow at a CAGR of around 10-12 per cent between FY2019-2022 ICRA has maintained a stable…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.